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Abstract 
 
Background: Frequent falls, progressive postural instability, and gait abnormalities are common 
functional impairments in patients with Progressive Supranuclear Palsy (PSP).  PSP can initially 
present like Parkinson’s Disease (PD), but these patients will show signs of progressing symptoms and 
poor response to dopaminergic therapy.  Physical therapy treatment for patients with PSP is largely 
understudied and there is no known effective pharmacotherapy. Thus, the purpose of this case study is 
to describe the short-term outcomes of a modified LSVT BIG program for a patient with PSP. Case 
Description: A 69-year old male, with a recent diagnosis of PSP, was treated in a hospital-based 
outpatient facility.  The patient and his wife were seeking treatment to assist with gait and postural 
instability, frequent falls, and impairments in bed mobility and cervical range of motion. Intervention:  
Treatment sessions consisted of postural and strengthening exercises, functional movement exercises, 
and balance exercises, with an emphasis on large-amplitude movements, adapted from the LSVT BIG 
program regimen.  The patient was instructed in a home program that emphasized large-amplitude 
movements and stretches in a safe environment.  Outcome Measures:  The Functional Gait 
Assessment, Berg Balance Scale, and the 6-Minute Walk Test were assessed to objectively measure 
the patient’s response to physical therapy interventions to improve or maintain his prior level of function 
in spite of the progressive nature of his diagnosis. Discussion: There is a need for more evidence-
based research to assist clinicians with symptomatic treatment of patients with PSP.  Due to the 
symptom progression in PSP, interventions, education, and goals should be focused on maintaining the 
patient’s quality of life and mobility status with strategies to minimize fall risk and increase patient and 
caregiver safety.  
 
Keywords: Progressive Supranuclear Palsy; neurology; rehabilitation; physical therapy; LSVT BIG; 
outcome measures; postural instability; falls 
 
 
 Modified LSVT BIG for PSP 
2 
© 2019 Brown, Elise 
Background 
Progressive Supranuclear Palsy (PSP) is a rare, progressive neurodegenerative disorder that is 
classified as an Atypical Parkinsonism Syndrome (APS), which can be differentiated from the typical 
Parkinson’s Disease (PD) diagnosis.  The hallmark sign of PSP is supranuclear gaze palsy, which is 
essentially vertical gaze palsy where the patient has difficulty with moving and tracking the eyes in 
superior and inferior directions.  PSP also presents itself with other Parkinsonism signs such as resting 
tremor, bradykinesia, and rigidity (Intiso, 2018).  Another hallmark sign of patients with PSP is gait 
abnormalities that can lead to sudden, unpredictable backward falls. Other motor signs include eyelid 
abnormalities, pseudobulbar palsy, slurred speech, and dysphagia (Sosner, 1993).  Mobility, speech, 
and swallowing are the most commonly experienced problems with aspiration pneumonia being the 
leading cause of death in these patients (Tilley, 2014).  Most patients are diagnosed with PSP in the 
60-70s age range and patients have a mean survival rate of about six years from age of onset and 
about two years following diagnosis (Sosner, 1993).    
The neuropathology of this disease is defined as a “taupathy,” meaning it is a disease caused 
by the accumulation of hyperphosphorylated tau proteins primarily in the basal ganglia, brainstem, 
dentate nucleus, and oculomotor nuclei (Intiso, 2018). Other pathological signs of PSP include “nerve 
cell loss, gliosis, granulovascuolar changes, and atypical neurofibrillary tangles in the basal ganglia” 
(Sosner, 1993).  To this date, there is no effective treatment with pharmacologic therapy to modify the 
pathophysiology of tau-associated neurodegeneration, and treatment remains symptomatic (Intiso, 
2018). There are many taupathy phenotypes described within the diagnosis of PSP and the differences 
are likely due to topographical variations of tau protein pathology and/or differences in density of 
deposition in the specific cerebral regions.  The most common phenotype for PSP is the PSP-
Richardson’s syndrome type.  This phenotype is typically characterized by “early gait instability, falls, 
supranuclear gaze palsy, axial rigidity, dysarthria, dysphagia, and progressive dementia” (Intiso, 2018; 
Tilley, 2014).   
Neurologists can clinically diagnose PSP using the National Institute for Neurological Disorders 
and Stroke (NINDS) and the Society of Progressive Supranuclear Palsy (SPSP) criteria (Tilley, 2014).  
Patients have to meet a set of inclusion criteria and deny or not present with any other symptoms of 
other neurological conditions within the set of exclusion criteria.  Diagnosis categories include 
“probable”, “possible”, and “definite” diagnosis of PSP.  A “definite” diagnosis of PSP can only be 
confirmed post-mortem with findings of abnormal tau protein in the basal ganglia, brainstem, and cortex 
(Tilley, 2014).  
Current research has not led to a cure for PSP and pharmacological management with 
levodopa has shown little therapeutic effect for this patient population (Tilley, 2014).  There is very little 
research to be found on the possible beneficial effects of rehabilitation strategies for patients with PSP 
and what the specific interventions should entail for the best outcomes.  Many of the treatments to 
assist with independence and optimal functioning of patients with PSP are inferred from data collected 
from patients with PD (Tilley, 2014).  Therefore, the purpose of this case report is to describe the use of 
a modified LSVT BIG protocol for large amplitude-based movements more typically used in patients 
with PD and its short-term outcomes for a patient with PSP.  
 
Case Study Description 
Initial Evaluation 
 A 69-year-old male was evaluated at a hospital-based outpatient facility with a medical 
diagnosis of Progressive Supranuclear Palsy.  He was diagnosed three months earlier at a major-
medical center, although this diagnosis was suspected prior to the official diagnosis due to the patient’s 
presentation.  The patient and his wife were present for the subjective interview and objective portion of 
the evaluation. This patient was previously seen at this outpatient facility in 2018 following a diagnosis 
of Parkinson’s Disease in 2016, where he was evaluated and treated for balance and mobility 
impairments with the LSVT BIG program.  At that time, the patient responded very favorably to the 
treatment interventions.  
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During this evaluation, the patient provided some of the subjective responses to the questions 
asked, but his wife was able to provide a more detailed history and she had brought in a list of notes to 
share with us.  The patient reported that his “brain fog” was the worst it has been, his balance was 
impaired causing him to fall backwards more often but with no reported injuries, and reports doing 
better in the morning and declines by about 2:00 in the afternoon.  The wife provided additional 
information about the patient’s presentation and progression since his last treatment with physical 
therapy in 2018.  She reported rolling in bed and getting up out of the chair at night was extremely 
difficult for the patient, requiring “brute force” to complete.  She notes her husband was more impulsive 
and reckless with his movements and this causes him to fall, noting “his body moves faster than his 
brain is.”  She also comments on his difficulty with swallowing, eating, fine motor skills, and moving his 
neck due to stiffness.  She reports many troubles with his eyes, including focusing his eyes, trouble 
keeping his eyes open, difficulty scanning with his eyes to find objects, and having his eyes get stuck in 
the “up position.”  The patient and his wife voice their biggest concern being his balance and frequent 
falls.  They report five falls during the week prior to his evaluation, with most of his falls occurring to the 
side or backwards.  Most of his falls occurred when going from sitting to a standing position and once 
he is standing and his feet get tangled up.  The patient was not currently using an assistive device at 
home or in the community, but his wife was interested in trialing devices that would help with his safety.   
His goals for physical therapy included improving his balance and postural control.   
 
Examination and Evaluation 
 A variety of objective tests and measures 
were utilized to classify this patient’s fall risk, 
balance impairments, aerobic capacity, and 
cervical range of motion.  The patient was not 
using an assistive device or gait belt at the time of 
evaluation.  Observation of this patient revealed a 
forward head and rounded shoulders posture, with 
lateral leaning noted in sitting.  The patient’s gait 
was analyzed during the 6 Minute Walk Test 
(6MWT), with the patient demonstrating minimal to 
no reciprocal arm swing, mild forward and lateral 
trunk leaning, mild path deviations with ambulating 
a longer distance, shuffling gait that was able to 
be corrected with verbal cues, somewhat 
inconsistent speed but demonstrated symmetrical 
step length, and a normal base of support with 
occasional narrowing of his feet.  The patient was 
able to walk 439.5 meters without an assistive 
device (1.22 m/s) which can be interpreted as a 
borderline normal gait speed for his age (1.2-1.4 
m/s for patients 13-69 years old).  The patient was also instructed in completing a battery of balance 
tests including the Functional Gait Assessment (FGA), Berg Balance Scale (BBS), Timed Up and Go 
(TUG), and Modified CTSIB.  The patient’s lower extremity functional strength was assessed utilizing 
the 5 Time Sit to Stand Test (5STS) and cervical range of motion (ROM) was also measured. The 
scores of these outcome measures and other assessments can be found in Table 1.  
 The goals for this patient were determined utilizing the patient and wife’s subjective comments 
on their main concerns and the physical therapist’s impression based on the patient’s presentation.  
 
 
  
Table 1. Initial evaluation outcome scores.   
 
Test Results 
FGA 17/30 
BBS 33/56 
6MWT 439.5 m (1.22 m/s) 
TUG 10.5 seconds and 9.2 seconds 
Modified 
CTSIB 
30 seconds EO on ground and 
foam; 15 seconds EC on ground 
(LOB to R); 10 seconds EC on 
foam (LOB to R) 
5STS 31.5 seconds (required occasional 
minimum assist) 
Cervical 
ROM  
Flexion (40 degrees) 
Extension (50 degrees) 
R Rotation (40 degrees) 
L Rotation (45 degrees) 
EO (eyes open), EC (eyes closed), LOB (loss of balance), R 
(right), L (left) 
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Clinical Impression 
Following the examination, the physical therapy diagnoses included bradykinesia, postural 
instability, balance impairments, shuffling gait pattern, hypokinesia, impaired motor planning, resting 
tremor, and limited cervical ROM.  Based upon examination findings, we felt this patient would be an 
appropriate candidate to participate in skilled physical therapy and could potentially benefit from large 
amplitude-based movement interventions to address the various aspects of his clinical presentation (i.e. 
bradykinesia, impaired motor planning, hypokinesia, etc).  With this patient’s recent diagnosis of PSP 
and familiarity with the LSVT BIG program during his last plan of care, he was considered to be an 
appropriate candidate for a modified LSVT BIG protocol.  
As mentioned previously, the patient ambulated with minimal arm swing and a shuffling gait 
pattern which we could address with increasing his step height, step length, and reciprocal arm swing 
with large-amplitude exercises and cues emphasizing these movements in hopes of motor control carry 
over into his daily life.  This patient also lacked cervical ROM within normal limits due to muscular 
stiffness and hypokinesia of the cervical spine, and the large amplitude-based exercises would include 
cervical movements to help improve his flexibility.  The modified LSVT BIG program would also benefit 
the patient from its overall benefits on flexibility and posture since he presented with a significant 
forward head and rounded shoulders posture with a lateral lean in sitting.  Our interventions would 
include large amplitude postural strengthening and stretching exercises to address these deficits.   
Due to the progressive nature of his diagnosis, we suggested the patient receive skilled physical 
therapy treatments three times per week for one-hour sessions with a student physical therapist and 
supervising physical therapist who was certified in administering the LSVT BIG program and could 
provide recommendations for modifications to the interventions based on her knowledge of the 
program.  Although this patient would not be partaking in the LSVT BIG program in its full completion 
and structured regimen, the intervention strategies utilized in the BIG program would be incorporated 
into his skilled intervention sessions.   
 
Intervention 
Evidence-Based Research for LSVT BIG 
The Lee Silverman Voice Treatment (LSVT) BIG therapy program is an example of a 
therapeutic intervention designed to promote neuroplasticity in patients with PD by conducting task 
specific, high-intensity training (Fishel, 2018).  This program includes a total of 16 sessions performed 
over four weeks, with one-hour sessions four times per week.  Each session focuses on large 
amplitude movements which can improve speed and quality of movement during trained and untrained 
tasks (Fishel, 2018).  There is an initial assessment and follow-up reassessment to determine the 
outcomes of the program and the attainment or progress towards the patient and therapist’s goals.  
Patients are encouraged to work at 80% of their maximal energy on every repetition during the LSVT 
BIG protocol exercises (Ebersbach, 2010).  Patients are also taught to use bigger movements in 
routine, daily activities when they are not in skilled therapy sessions to provide continuous exercise in 
everyday movements (Ebersbach, 2010).  
The intervention chosen for this case study was for a modified LSVT BIG program due to its 
well-researched benefits for patients with PD.  The patients selected for this program undergo  
intensive, four-times-a-week therapy sessions for four weeks with a certified instructor for the LSVT BIG 
program.  Each of the individual training sessions include a structured set of components.  These 
include Maximum Daily Exercises, Functional Component Tasks, BIG Walking, and Hierarchy Tasks 
(Fishel, 2018). The Maximum Daily Exercises incorporate seven standardized exercises that are done 
in either a sitting or standing position and consist of multidirectional movements of the body.  They are 
also performed as a part of the home exercise program, at a high number of repetitions, and at a high 
level of perceived effort (about 80%).  The patient also picks five Functional Component Tasks that are 
based off the patient’s goals and the therapist’s evaluation findings.  These are performed repeatedly 
during each session with emphasis on increasing the amplitude of movement, with sit-to-stands 
included for each patient.  BIG Walking is also completed at each session with the patient focused on 
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increasing step length and arm movement throughout the activity.  The Hierarchy Tasks are based 
upon one to three patient selected functional goals with the therapist designing movements to help 
improve each skill. Each week the task is adapted to progress the complexity and the patient is 
encouraged to practice these skills in their home environment to assist with carryover into their daily 
life. Patients are instructed in a home exercise program based on the LSVT BIG program to complete 
one time a day when seen by the therapist and two times a day when not in the clinic (Fishel, 2018).   
 A recent systematic review on the LSVT BIG program’s effect on the motor function of patients 
with mild PD revealed significant improvements in motor function after participation in the LSVT BIG 
program as compared to control groups with other exercise protocols (McDonnell, 2017).  However, 
there has been limited research conducted on the effects of the LSVT BIG program in patients with 
moderate PD, as well as the effects of the program on other Parkinsonian diagnoses such as PSP.  
One study of three patients with moderate PD found clinically meaningful improvements in postural 
control, and more specifically with dual-tasking following LSVT BIG training (Fishel, 2018).  The 
patients in this study also tolerated the high intensity nature of the program and maintained their 
improvements for four months following their reassessments.  A novel finding of this study was the 
improved motor cognitive dual-task abilities in patients following LSVT BIG which in an impairment that 
a majority of people with Parkinsonian diagnoses have difficulty with.  During their interventions, dual-
task activities were added to increase the complexity of the exercise in the clinic but not specifically 
targeted at home.  It is proposed that these effects may be due to improved automaticity of the motor 
program so that the patient has a greater ability to attend to the cognitive task (Fishel, 2018).   
 
Case Study Interventions  
 This case study patient participated in 
interventions modified from the LSVT BIG 
program that the supervising therapist was 
certified to administer.  Each session was 
unique and did not follow a set exercise 
protocol, but incorporated large amplitude-
based functional movements, large 
amplitude-based postural 
strengthening/stretching exercises, balance 
training, and instruction in a home exercise 
program. Table 2 outlines a general overview 
of the interventions included during the nine 
therapy sessions with this patient. The 
sessions also consisted of utilizing the 0-10 
Borg Rating of Perceived Exertion (RPE) 
scale to gain a subjective measurement of 
total body exertion, with the goal of a 7-8 
rating with each exercise, correlated to about 
75-85% effort.  See Figure 1 for full details of 
the RPE scale used with this patient.    
Throughout the course of this patient’s 
care, patient and family education was 
incorporated for the safety of the patient, his 
wife, and his other caregivers.  Because of 
the progression of the disease, the patient 
was instructed on strategies to reduce the 
frequency of falling.  This education included 
recommendations to not multi-task as he was 
Table 2. Interventions during therapy sessions.    
 
Functional 
Movements 
Posture 
Strengthening/ 
Stretching 
Walking with reciprocal 
arm swing 
Sidelying T-spine 
mobility (open-book) 
Backwards walking Foam roller pec stretch 
Side stepping Cat/camel 
Turning 360 degrees Prone press ups 
Sit to stands Lat pulldowns 
Lunges Scapular retractions 
Bridges, rolling, 
sidelying <> sit 
transition 
Trunk flexion rollouts on 
swiss ball 
ICARE elliptical Forward reaching to 
targets on ground 
 
Balance Home Exercise 
Program 
Static stance: 
- Feet staggered 
- Feet together  
- Head nods/turns 
- Eyes open/ 
closed 
- Foam  
Proprio (reactive 
balance system) 
Marching 
Side steps 
Bridges  
Static lunges  
Scapular retractions 
Sidelying T-spine 
mobility (open book) 
Supine pec stretch 
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walking so that he could maintain his focus on 
his balance.  He was also encouraged to have 
something or someone to hold onto if he was 
standing statically in an open space due to his 
unsteadiness and tendency to lean backwards.  
The patient and his wife were also provided with 
recommendations and measurements for 
medical equipment to purchase for home 
including a rolling shower chair, grab bars, and a 
weighted walker.  During some therapy sessions, 
the patient would utilize a bariatric walker to 
simulate what a weighted walker would feel like 
to help him maintain his balance and stability 
with walking activities.  
A home program was designed and 
progressed throughout his plan of care to 
incorporate similar movements performed in 
therapy, but with slightly less complicated 
movements to ensure the patient’s safety at 
home.  He and his wife were encouraged to 
perform these exercises three to four times per 
week (on days he was not in therapy) in order to 
maintain and improve his strength, balance, posture, and ease with bed mobility.   
 
Outcomes 
 There are no specific literature articles 
citing recommended outcome measures for 
patients with PSP.  However, a narrative review 
by Intiso et al. in 2018, cumulated 16 studies of 
patient with PSP and indicated a wide variety of 
outcome measures to be considered. The 
outcome measures that were assessed at this 
patient’s initial evaluation and reassessment day 
(nine visits after the initial evaluation) included 
recommended tests and measures for patients 
with PD and for various populations of older 
adults, including outcome measures utilized in 
the narrative review by Intiso et al.  At the tenth visit reassessment, the patient completed the FGA, 
BBS, 6MWT and 5STS tests to analyze the progress towards reaching the patient’s goals in the 
previous three and a half weeks.  See Table 3 for a summary of the patient’s outcome scores at his 
reassessment.   
The Functional Gait Assessment (FGA) is a 10-item standardized test for assessment of 
postural stability during various walking tasks with a maximum score of 30 points indicating superior 
performance with scores on each individual test ranging from 0-3 (Ellis, 2011).  The FGA is considered 
a “recommended” evaluation tool for patients with PD and measures dynamic balance during gait.  The 
benefit of using the FGA over the Freezing of Gait Questionnaire is the assessment of walking speed, 
turning, changing speeds and directions, and navigating obstacles (Bloem, 2016; Ellis, 2011). This 
patient improved his FGA score by 2 points; he demonstrated an improved normal gait speed and 
improved his ability to walk forward with his eyes closed with minimal path deviations.  This did not 
meet the criteria for a minimal detectable change (MDC) for the FGA, with an improvement of 4 points 
indicating the minimum amount of change in a patient's score that ensures the change isn't the result of 
Table 3. Reassessment outcome scores.   
 
Test Results 
FGA 19/30  (+2 improvement) 
BBS 31/56  (-2 decline) 
6MWT 350.5 m (0.97 m/s)  (-89 m; -0.25 m/s 
decline) 
5STS 34 seconds (required occasional 
min-mod assist) (+2.5 sec worse) 
Note: The parenthesis denote the improvement or decline 
in outcome scores.  
Figure 1. 0-10 Borg Rating of Perceived 
Exertion Scale 
 
0 Rest 
1 Really Easy 
2 Easy 
3 Moderate 
4 Sort of Hard 
5 
Hard 
6 
7 
Really Hard 
8 
9 Really, Really Hard 
10 Maximal 
(Adapted from https://exercise.trekeducation.org/assessment/ 
borg-scale-rpe/) 
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measurement error.  The FGA has excellent inter and intrarater reliability (ICC – 0.99; 95% CI = 0.99-
1.00) and excellent test-retest reliability with administration by PT students (ICC = 0.86) (Shirley Ryan 
AbilityLab).  The FGA also has excellent concurrent validity between its score and the BBS score.  The 
FGA has moderate overall validity and its highest correlation is with the BBS for identifying patients with 
PD who fall (Leddy, 2011).  Even though this patient’s score improved and is found to be a reliable and 
valid test, his improved score does not meet the standard to ensure the amount of change was not due 
to measurement error.  
 The Berg Balance Scale (BBS) is a 14-item scale to assess static and dynamic balance and risk 
for falls through observation of performance of each task, with individual test scores ranging from 0-4 
with a maximum score of 56 indicating better balance (Ellis, 2011).  The BBS has excellent test-retest 
reliability (ICC = 0.94) and excellent interrater reliability (ICC = 0.95) with sensitivity of 85% for 
predicting future falls (Shirley Ryan AbilityLab; Leddy, 2011).  This patient’s BBS score declined by 2 
points in the three and a half weeks following his initial evaluation, but this does not fall within the MDC 
of 5 points for patients with PD (Steffen and Seney, 2008).   
 The 6 Minute Walk Test (6MWT) is a test that measures the distance a patient walks in six 
minutes and calculates the average speed while allowing the patient to take as many rest breaks as 
needed with the time continuing to record.  The 6MWT has excellent test-retest reliability and an MDC 
score of 82 meters being the minimum amount of change that is not related to measurement error 
(Steffen and Seney, 2008). Although this patient demonstrated an 89-meter reduction in his distance 
walked in six minutes, the quality of his gait improved with the patient exhibiting an increase in step 
height and step length and improved initiation of arm swing without cueing.  The patient began to 
fatigue at the end the test and was shuffling his feet and taking shorter steps in the last two minutes.   
 The 5 Time Sit to Stand (5STS) test is a test used to quantify functional lower extremity strength 
and helps clinicians to identify movement strategies a patient may use to complete transitional 
movements (Shirley Ryan AbilityLab).  The 5STS test has a cutoff score of greater than 16.0 seconds 
indicating a risk of falls, an excellent test-retest reliability (ICC = 0.91), and an excellent interrater 
reliability (ICC = 0.99) in patients with PD (Duncan, 2011; Paul, 2012).  Interpretation of this patient’s 
score indicates his increased risk of falling with a total time to complete the test of 34.0 seconds.  He 
also continued to require minimum to moderate assistance to stand from the standard chair height of 18 
inches and was given frequent cues to encourage him to lean his trunk forward and use momentum 
with his arms outstretched to minimize his posterior weight shift.  
 
Discussion 
The purpose of this case report was to describe the use of a modified LSVT BIG protocol for 
large amplitude-based movements and its short-term outcomes for a patient with PSP.  Patients with 
PSP generally suffer from frequent falls in the posterior direction, bradykinesia, postural instability, and 
other symptoms that require the inclusion of physical, occupational, and speech therapy as a part of the 
interdisciplinary medical team.  Oftentimes, social work can provide assistance with family and 
caregiver resources and other information to provide ample education and support systems available in 
the community.   
Progressive Supranuclear Palsy can often be initially misdiagnosed as typical Parkinson's 
Disease, although these two are not synonymous.  Parkinsonian conditions can be broken down into 
Parkinson's Disease and atypical Parkinsonian conditions including PSP, dementia with Lewy bodies, 
multiple system atrophy and corticobasal degeneration (Tilley, 2014).  PSP presents very similarly to 
PD but does not respond to levodopa therapy as patients with PD do (Intiso, 2018).  In the early stages 
of PSP, the disease can present very similar to that of PD, as bradykinesia may be the only early sign 
of basal ganglia dysfunction in PSP.  It has been found that about 4% of patients with Parkinsonism 
turn out to have PSP (Sosner, 1993).  As compared to PD, patients with PSP have “rapid disease 
progression; poor, absent, or waning response to dopaminergic medications; and an earlier 
presentation of instability, falls, dysphagia and/or dysarthria” (Tilley, 2014).  According to the NINDS-
SPSP criteria, exclusion criteria for a PSP diagnosis, because of prominent signs of PD, include 
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asymmetric onset of bradykinesia, a tremor-dominant disease, and sustained and obvious benefit with 
levodopa therapy (Tilley, 2014).  
Numerous studies have investigated interventional therapies for patients with traditional PD, 
with much less research investigating interventions for PSP.  The techniques supported by research for 
PD include balance training, aerobic activity, large amplitude movement training and many others to 
address functional impairments and activity limitations caused by muscle weakness, reduced aerobic 
capacity, gait instability, and balance impairments in this patient population.   
The LSVT BIG program was developed in 2002 for patients with PD, with the overarching goal 
of “restoring normal movement amplitude by recalibrating the patient’s perception of movement in 
execution” (Janssens, 2014).  The design of the LSVT BIG program emphasizes amplitude of 
movement rather than speed to help patients overcome slowness or absence of movement (ie. 
bradykinesia, hypokinesia).  The specificity of this type of training helps to improve movement 
amplitude and accuracy, whereas speed of movement training helps to train velocity and produce faster 
movements.  It is hypothesized with this treatment that a single cue for “bigger movements” may 
decrease the cognitive load and mental effort during movement tasks and possibly help to maintain and 
generalize the continuation of this movement strategy outside of therapy (Fox, 2012).    
Over the course of ten visits with this patient, there was improvement in some of the outcome 
measures while some measures declined.  The patient’s FGA score improved from a 17 to a 19 in three 
and a half weeks of therapy, but he remained a high fall risk since his score was less than 22/30 
(Shirley Ryan AbilityLab).  The patient also demonstrated improved volitional reciprocal arm swing that 
was noted during the reassessment of the 6MWT and with ambulation around the therapy gym during 
individual treatment sessions during the ten therapy visits.  Although he was not able to ambulate at the 
same speed as his initial evaluation, he continued to maintain a speed that fits within the walking speed 
of a community ambulator (0.8 – 1.2 m/s).  He also had fair carryover with the large amplitude 
exercises performed in therapy that translated into his daily transitions at home and during his therapy 
sessions.  The patient and his wife also subjectively reported about a 25% improvement in his bed 
mobility and sit to stand transfers at home.   
This case study points to the difficulty of providing effective treatment to show improvement in 
outcomes scores in patients with progressive diseases such as PSP in the clinical setting.  It can be 
extremely difficult to determine if a specific intervention “worked” or “didn’t work” or if the progression of 
the disease is causing a decline in the patient’s function that is unable to be matched by our treatment 
interventions.  For patients with a progressive disease, maintaining a prior level of function and 
performance is making “progress” in a sense.  It is still important to make meaningful goals to assist 
with the patient’s independence, strength, balance, posture, or other goals the patient hopes to achieve 
with therapy.  Clinicians must keep in mind that we may not be able to achieve notable improvement 
with therapeutic interventions secondary to the difficulty of treating patients with progressive conditions.   
Research in patients with PSP has not specifically focused on therapeutic interventions that are 
recommended for this population.  Interventions and goals for therapy should focus on maintaining 
quality of life and mobility; ensuring the safety of the patient, family and other caregivers; incorporating 
an interdisciplinary team consisting of speech and occupational therapy; educating the patient and 
family on compensatory strategies for activities of daily living; and providing recommendations and 
referrals for assistive devices and adaptive equipment as necessary.   
In summary, this case report fulfilled the purpose of describing the short-term outcomes of a 
modified LSVT BIG protocol for a patient with a recent diagnosis of PSP.  This particular patient had 
mixed results demonstrating some improvement and some decline with specific outcome measures 
related to gait, balance, strength, and aerobic capacity.  The patient’s family and friends played a 
significant supportive role in his care, assisting with home modifications, compliance with a home 
program, and keeping detailed reports of his progress and continued needs at home and within the 
community.   
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